Lee Pharmaceuticals, Inc.
AIMN
$0.01
$0.00-36.36%
OTC PK
| 06/30/2022 | 03/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 192.30K | 102.80K | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 192.30K | 102.80K | |||
| Operating Income | -192.30K | -102.80K | |||
| Income Before Tax | -542.10K | -277.60K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -542.10K | -277.60K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -542.10K | -277.60K | |||
| EBIT | -192.30K | -102.80K | |||
| EBITDA | -- | -- | |||
| EPS Basic | -0.11 | -0.05 | |||
| Normalized Basic EPS | -0.07 | -0.03 | |||
| EPS Diluted | -0.11 | -0.06 | |||
| Normalized Diluted EPS | -0.07 | -0.03 | |||
| Average Basic Shares Outstanding | 5.16M | 5.16M | |||
| Average Diluted Shares Outstanding | 5.16M | 5.16M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||